Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

The facility is the centrepiece of a 10-year agreement-in-principle between the biotech and the UK government – which has been rumoured to be on the cards ... of Moderna’s COVID-19 vaccine ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

Sen. Bill Cassidy (R-La.) said he secured significant concessions from the Trump administration on vaccine safety that led to ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are coming through the pipes if it does.

He opened the hearing by declaring that he was deeply troubled by Mr. Kennedy’s “past of undermining confidence in vaccines.” By the end, he wondered aloud whether Mr. Kennedy, 71 ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX).

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 ...